Patents by Inventor Xinwei LU

Xinwei LU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250003694
    Abstract: A heat transfer apparatus including a housing and a wick structure is provided that is configured to dissipate heat from a heat source. The housing defines a chamber that holds working fluid. The wick structure includes a body and pores defined by the body. The heat transfer apparatus defines an evaporator section configured to evaporate the working fluid using heat from a heat source and a condenser section configured to dissipate heat carried by the evaporated working fluid through condensation of the evaporated working fluid. The wick structure has a repeatable, configurable, and controlled geometry optimized to move the working fluid from the condenser section to the evaporator section via capillary action. The body of the wick structure may have a gyroidal geometry. Associated methods are also provided.
    Type: Application
    Filed: July 18, 2023
    Publication date: January 2, 2025
    Inventors: Ron CHAO, Elad Mentovich, Harrison Sangwha Kim, Mark North, Xinwei Lu, Tahir Cader, Fei Zhang, Yunseok Kim, David Haley, Yuezhan Steven Zhu, Lei Huang
  • Patent number: 11697655
    Abstract: A preparation method of an intermediate compound of formula II ((1R,2S,3S,4S,5S,6R,11S,14S,17S,19R,21R,23S,25R,26R,27S,31R,34S)-25-[(2S)-2,3-dihydroxy]-2,5-dihydroxy-26-methoxy-19-methyl-13,20-dimethylene-24,35,36,37,38,39-hexaoxane[29.3.1.13,6.14,34.111,14.117,21.023,27]nonatriacontan-8,29-dione) for eribulin mesylate is provided, including subjecting a compound of formula I to a reaction with an additive in the presence of tetra-n-butylammonium fluoride (TBAF). The additive is piperidine hydrochloride or pyridine hydrochloride, and a reaction formula is as follows: The present invention aims to avoid the problem that a traditional synthetic route has a low yield.
    Type: Grant
    Filed: November 5, 2021
    Date of Patent: July 11, 2023
    Assignee: WISDOM PHARMACEUTICAL CO., LTD
    Inventors: Xiaolong Qiu, Tao Xu, Zhiwei Zuo, Jie Ge, Xinwei Lu, Lingling Chu, Wenbo Liu, Biao Wang, Tingwei Gu, Weiwei Wang, Lin Hu, Ping Zou, Jun Chen, Lei Cao
  • Publication number: 20220402933
    Abstract: A preparation method of an intermediate compound of formula II ((1R,2S,3S,4S,5S,6R,11S,14S,17S,19R,21R,23S,25R,26R,27S,31R,34S)-25-[(2S)-2,3-dihydroxy]-2,5-di hydroxy-26-methoxy-19-methyl-13,20-dimethylene-24,35,36,37,38,39-hexaoxane[29.3.1.13,6.14,34.111,14.117,21.023,27]nonatriacontan-8,29-dione) for eribulin mesylate is provided, including subjecting a compound of formula I to a reaction with an additive in the presence of tetra-n-butylammonium fluoride (TBAF). The additive is piperidine hydrochloride or pyridine hydrochloride, and a reaction formula is as follows: The present invention aims to avoid the problem that a traditional synthetic route has a low yield.
    Type: Application
    Filed: November 5, 2021
    Publication date: December 22, 2022
    Applicant: WISDOM PHARMACEUTICAL CO., LTD
    Inventors: Xiaolong QIU, Tao XU, Zhiwei ZUO, Jie GE, Xinwei LU, Lingling CHU, Wenbo LIU, Biao WANG, Tingwei GU, Weiwei WANG, Lin HU, Ping ZOU, Jun CHEN, Lei CAO